...
首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Encapsulation of methyl and ethyl salicylates by beta-cyclodextrin HPLC, UV-vis and molecular modeling studies.
【24h】

Encapsulation of methyl and ethyl salicylates by beta-cyclodextrin HPLC, UV-vis and molecular modeling studies.

机译:通过β-环糊精HPLC,UV-vis和分子模型研究对水杨酸甲酯和水杨酸乙酯进行封装。

获取原文
获取原文并翻译 | 示例
           

摘要

The complexation of methyl salicylate (MS) and ethyl salicylate (ES), non-steroidal analgesic, anti-inflammatory and antirrheumatic drugs with beta-cyclodextrin (betaCD) has been studied from thermodynamic and structural points of view. The complexation with betaCD has been investigated using reversed-phase liquid chromatography. Retention behavior has been analyzed on a reverse-phase column Luna 18(2) 5 microm. The mobile-phase was methanol:water in different ratios (55:45 to 70:30) in which betaCD (1-9 mM) was incorporated as a mobile-phase additive. The decrease in retention times with increasing concentrations of betaCD enables the determination of the apparent stability constant of the complexes. Values at 30 degrees C with 55% methanol were K(MS:betaCD): 15.84 M(-1) and K(ES:betaCD): 12.73 M(-1) for MS and ES, respectively. The apparent stability constants decrease as the polarity of the solvent decreases. The low solubility of MS and ES in aqueous solution has been improved by complexation with betaCD (1-9 mM). The stability constants of the complexes obtained from the phase-solubility diagrams using a UV-vis spectrophotometric method were K(MS:betaCD): 229 M(-1) and K(ES:betaCD): 166 M(-1). In addition, semi-empirical quantum mechanics calculations using AM1 and PM3 methods in vacuum were performed. The energetically favorable inclusion structures were identified and the most favorable orientation for the inclusion process was found to be the head-down orientation for both complexes. Enthalpy for encapsulation processes was found to be favorable (DeltaH degrees <0), while entropy (DeltaS degrees <0) and Gibbs free energy were unfavorable (DeltaG degrees >0). By means of HPLC and UV-vis measurements and quantum mechanics calculations, it was found that MS and ES form a 1:1 inclusion complex with betaCD. The theoretical results are in agreement with the experimental parameters associated with the encapsulation process.
机译:从热力学和结构的角度研究了水杨酸甲酯(MS)和水杨酸乙酯(ES),非甾体镇痛药,抗炎药和止痛药与β-环糊精(βCD)的络合作用。已经使用反相液相色谱法研究了与βCD的络合。在反相色谱柱Luna 18(2)5 microm上分析了保留行为。流动相为不同比例(55:45至70:30)的甲醇:水,其中以βCD(1-9 mM)作为流动相添加剂。随着βCD浓度的增加,保留时间的减少使得能够确定复合物的表观稳定性常数。对于MS和ES,在30°C下使用55%甲醇的值分别为K(MS:betaCD):15.84 M(-1)和K(ES:betaCD):12.73 M(-1)。表观稳定性常数随着溶剂极性的降低而降低。 MS和ES在水溶液中的低溶解度已通过与betaCD(1-9 mM)的络合得到了改善。使用紫外可见分光光度法从相溶解度图中获得的配合物的稳定常数为K(MS:betaCD):229 M(-1)和K(ES:betaCD):166 M(-1)。此外,在真空中使用AM1和PM3方法进行了半经验量子力学计算。确定了能量上有利的包合物结构,发现包合物过程最有利的取向是两种配合物的正面向下取向。发现封装过程的焓是有利的(DeltaH度<0),而熵(DeltaS度<0)和吉布斯自由能是不利的(DeltaG度> 0)。通过HPLC和UV-vis测量以及量子力学计算,发现MS和ES与betaCD形成1:1的包合物。理论结果与与封装过程相关的实验参数一致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号